dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Brodie, Martin |
dc.contributor.author | Czapinski, Piotr |
dc.contributor.author | Pazdera, Ladislav |
dc.contributor.author | Sander, Josemir |
dc.contributor.author | Toledo Argany, Manuel |
dc.contributor.author | Napoles, Mariana |
dc.date.accessioned | 2022-06-20T08:43:06Z |
dc.date.available | 2022-06-20T08:43:06Z |
dc.date.issued | 2021-12 |
dc.identifier.citation | Brodie MJ, Czapinski P, Pazdera L, Sander JW, Toledo M, Napoles M, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res. 2021 Dec;6(6):528–536. |
dc.identifier.issn | 2378-8763 |
dc.identifier.uri | https://hdl.handle.net/11351/7720 |
dc.description | Fàrmac antiepilèptic; Cannabinoide; Epilèpsia |
dc.description.sponsorship | The trial was sponsored by GW Research Ltd. |
dc.language.iso | eng |
dc.publisher | Mary Ann Liebert |
dc.relation.ispartofseries | Cannabis and Cannabinoid Research;6(6) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Convulsions - Tractament |
dc.subject | Cannabinoides - Ús terapèutic |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Seizures |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Treatment Outcome |
dc.subject.mesh | Cannabinoids |
dc.title | A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1089/can.2020.0075 |
dc.subject.decs | convulsiones |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | resultado del tratamiento |
dc.subject.decs | cannabinoides |
dc.relation.publishversion | https://doi.org/10.1089/can.2020.0075 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Brodie MJ] Epilepsy Unit, University of Glasgow, Glasgow, United Kingdom. [Czapinski P] Epilepsy and Migraine Treatment Center, Krakow, Poland. [Pazdera L] Vestra Clinics - Dedicated Research Clinics, Rychnov nad Kneznou, Czech Republic. [Sander JW] NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London, United Kingdom. Chalfont Centre for Epilepsy, Chalfont St. Peter, United Kingdom. Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, Netherlands. [Toledo M] Unitat d’Epilèpsia, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Napoles M] GW Research Ltd, Cambridge, United Kingdom |
dc.identifier.pmid | 33998885 |
dc.identifier.wos | 000621609100001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |